Lack of interaction between thioctic acid, glibenclamide and acarbose

British Journal of Clinical Pharmacology

Volumn 48, Issue 6, 1999, Pages 819-825

  Gleiter, C H ^a,d   Schreeb, K H ^a   Freudenthaler, S ^a   Thomas, M ^a   Elze, M ^b,e   Fieger Buschges H ^b   Potthast, H ^b   Schneider, E ^c   Schug, B S ^b,f   Blume, H H ^b,f   Hermann, R ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

^c ASTA MEDICA AG   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Pharmaceutical Research Associates   (Germany)

^f SocraTec R and D   (Germany)

Author keywords

Acarbose; Enantiomers; Glibenclamide; Glucose; Healthy volunteers; Insulin; Interaction; Thioctic acid; lipoic acid

Indexed keywords

ACARBOSE; GLIBENCLAMIDE; GLUCOSE; INSULIN; THIOCTIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; ENANTIOMER; FEMALE; GLUCOSE BLOOD LEVEL; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; NERVOUSNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEATING; TREMOR; VERTIGO;

EID: 0032786403     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00097.x     Document Type: Article

References (15)

1. 1 Suzuki JY, Tsuchyia M, Packer L. Lipoic acid and dihydrolipoic acid are novel antioxidants which react with reactive oxygen species. Free Rad Res Commun 1991; 15: 255-263.
2. 2 Suzuki JY, Tsuchyia M, Packer L. Lipoate prevents glucose-induced protein modifications. Free Rad Res Commun 1992; 17: 211-217.
3. 3 Jacob S, Clancy DE, Schiemann AL, et al. Verbesserung der Glukoseverwertung bei Patienten mit Typ-II-Diabetes mellitus unter α-Liponsäure (Thioctsäure). Diabetes Stoffu' 1996; 5(Suppl 3): 64-70.
4. 4 Ziegler D, Hanefeld M, Ruhnau KJ, et al. and the ALADIN study group. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant α-lipoic acid. Diabetologia 1995; 38: 1425-1433.
5. 5 Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patinets. A 4-month randmized controlled multicenter trial (DEKAN study). Diabetes Care 1997; 20: 369-373.
6. 6 Hermann R, Niebch G, Borbe HO, et al. Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. Eur J Pharmaceut Sci 1996; 4: 167-174.
7. 7 Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In Goodman and Gilman's the Pharmacological Basis of Therapeutics, eds. Hardman JG, et al. New York: McGraw-Hill., 1996: 1487-1518.
8. 8 Marchetti P, Giannarelli R, di Carlo A, Navalesi R. Pharmacokinetic optimization of oral hypoglycemic therapy. Clin Pharmacokinet 1991; 21: 308-317.
9. 9 Clissold SP, Edward C. Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1988; 35: 214-243.
10. 10 Ahr HJ, Boberg M, Krause HP, et al. Pharmacokinetics of acarbose. Part I. Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man. Arzneim Forsch/Drug Res 1989; 39: 1254-1260.
11. 11 Gleiter CH, Schug BS, Hermann R, Elze M, Blume HH, Gundert-Remy U. Influence of food intake on the bioavailability of thioctic acid enantiomers. Eur J Clin Pharmacol 1996; 50: 513-514.
12. 12 Niebch G, Büchele B, Blome J, et al. Enantioselective high-performance liquid chromatography assay of (+ ) R-and (-) S-α-lipoic acid in human plasma. Chirality 1997; 9: 32-36.
13. 13 Blume H, Stenzhorn G, Ali SL. Zur Bioverfügbarkeit und pharmakodynamischen Aktivität handelsüblicher Glibenclamid-Fertigarzneimittel, I. Mitt. Pharmazeut Zeitung 1985; 130: 1064.
14. 14 Steinijans VW, Hartmann R, Huber R, Radtke HW. Lack of pharmacokinetic interaction as an equivalence problem. Int J Clin Pharmacol Ther Toxicol 1991; 29: 232-328.
15. 15 Schug BS, Fieger-Büschges H, et al. Single and multiple dose administration of α-lipoic acid in a replicate study design (Abstract). Eur J Clin Pharmacol 1996; 50: 553.